# Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer Patients

> **NCT01618474** · PHASE2 · UNKNOWN · sponsor: **Tianjin Medical University Cancer Institute and Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Stomach Cancer

## Interventions

- **DRUG:** DX
- **DRUG:** XELOX

## Key facts

- **NCT ID:** NCT01618474
- **Lead sponsor:** Tianjin Medical University Cancer Institute and Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-05
- **Primary completion:** 2016-11
- **Final completion:** 2016-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2015-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01618474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01618474, "Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer Patients". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01618474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*